Interferon beta treatment in multiple sclerosis: the European clinical trials

Abstract

Keywords

multiple sclerosis interferon beta clinical trials MRI

Get full access to this article

View all access options for this article.

References

1 Comi G et al. (1995) Early treatment of multiple sclerosis with Rebif (recombinant human interferon beta): design of the study. Multiple Sclerosis 1; (suppl 1): 24–27.

2 Fernandez O et al. (1995) Treatment of relapsing-remitting multiple sclerosis with natural interferon beta: a multicenter randomized clinical trial. Multiple Sclerosis 1; (suppl 1): 67–69.

3 Fieschi C . (1995) Human recombinant interferon beta in the treatment of relapsing-remitting multiple sclerosis. Neuroimmunol (suppl 1): 14 (abstract).

4 Filippi M et al. (1995a) Correlations between changes in disability and T2 — weighted brain MRI activity in multiple sclerosis: a follow-up study. Neurology 45: 255–260.

5 Filippi M et al. (1995b) Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. Brain 118: 1601–1612.

6 Filippi M et al. (1995c) Brain magnetic resonance imaging and multimodal evoked potentials in benign and secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiat 58: 31–37.

7 Gass A et al. (1994) Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 36: 62–67.

8 Jacobs L . (1995) New perspectives in treatment of MS: results with recombinant interferon beta-1a. J Neuroimmunol (suppl 1): 14 (abstract).

9 Paty DW , Li DK , UBC MS/MRI study group and the IFNB multiple sclerosis study group . (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43: 662–667.

10.

10 Stone LA et al. (1995) The effects of interferon-β on blood-brain barrier disruption demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis. Ann Neurol 37: 611–619.

11.

11 The IFNB Multiple Sclerosis study group . (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43: 655–661.

12.

12 The IFNB Multiple sclerosis study group and the university of British Columbia MS/MRI analysis group . (1995) Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 45: 1277–1285.

13.

13 Van Walderveen MAA et al. (1995) Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short TR/short TE (T1 — weighted) spin-echo images. Neurology 45: 1684–1690.

14.

14 Weinshenker BG et al. (1991) The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 114: 1045–1050.

15.

15 Weinshenker BG et al. (1989) The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 112: 1419–1428.